Filing Flows › Clover Health Investments (CLOV) › Q2 2026 › vs Q2 2025
Clover Health Investments (CLOV) Q2 2026 vs Q2 2025 (year over year)
Clover Health Investments's revenue rose $266M (+56%) from $478M in Q2 2025 to $743M in Q2 2026. Operating margin 3.8% against -2.2% (+6.0 pts).
Clover Health Investments, Q2 2026: revenue $743M (+56% year over year), operating margin 3.8%, net earnings $28.0M, operating cash flow $25.2M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Operating margin | 3.8% | -2.2% | +6.0 pts |
| Net margin | 3.8% | -2.2% | +6.0 pts |
| Free cash flow margin | 3.3% | 1.0% | +2.3 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $743M | $478M | $266M | +56% |
| Operating profit | $28.0M | −$10.6M | $38.6M | — |
| Costs & expenses | $715M | $488M | $227M | +46% |
| Pre-tax earnings | $28.0M | −$10.6M | $38.6M | — |
| General & admin | $70.3M | $48.5M | $21.8M | +45% |
| Other operating costs | $645M | $440M | $205M | +47% |
| Net earnings | $28.0M | −$10.6M | $38.6M | — |
| Share-based compensation | $9.1M | $26.2M | −$17.1M | -65% |
| Working capital & other | $11.9M | $10.2M | $1.7M | +17% |
| Operating cash flow | $25.2M | $5.4M | $19.8M | +366% |
| Free cash flow (OCF − capex) | $24.5M | $4.8M | $19.7M | +406% |
| Capital expenditures | $682K | $569K | $113K | +20% |
Questions
How much did Clover Health Investments's revenue grow year over year in Q2 2026?
Clover Health Investments's revenue rose $266M (+56%) from $478M in Q2 2025 to $743M in Q2 2026. Operating margin 3.8% against -2.2% (+6.0 pts).